Clinical trial
Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior
NCT00368290 · Kyle Kampman, Other · Completed
Key facts
| NCT number | NCT00368290 |
|---|---|
| Title | Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior |
| Official title | Modafinil Treatment for Cocaine Dependence and HIV-High Risk Behavior |
| Acronym | MOD6 |
| Lead sponsor | Kyle Kampman, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Dependence |
| Intervention type | Behavioral, Drug |
| Interventions | Modafinil, placebo, Cognitive Behavioral Therapy (CBT) |
| Enrollment | 94 |
| Start date | Sep 1, 2006 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Aug 24, 2006 |
| Last update posted | Mar 15, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: